comparemela.com

Latest Breaking News On - M ali khan - Page 1 : comparemela.com

Renowned historian J.G.A. Pocock, who upended the study of political thought, dies at 99

Considered one of the great historians of his generation, Pocock wove philosophy, political science, and history into a program in political and moral thought that Hopkins is known for today

Greece
United-states
Italy
United-kingdom
Cambridge
Cambridgeshire
London
City-of
Rome
Lazio
Otago
New-zealand

Promoting Treatment Adherence in nAMD and DME

Retina specialists discuss treatment and adherence strategies for patients with nAMD and DME. They also comment on the future of nAMD and DME management.

M-ali-khan
Bali-khan
Extending-treatment-intervals
Durable-therapies
Diabetic-macular
Snamd
Dme
Treatment-adherence
Anti-vegf-therapy
Dropout
Tyrosine-kinase

Selecting Therapies for Individual Patients in nAMD and DME

Retina specialists discuss factors to consider when selecting a therapy for patients with neovascular AMD and DME as well as loading-dose recommendations for select patients.

M-ali-khan
Bali-khan
Snamd
Dme
High-dose-aflibercept
Treatment-naive-patient
Controlled-patient
Treat-to-dry

Switching Patients From 2mg to 8mg Aflibercept for nAMD and DME Treatment

Retina specialists comment on switching patients from 2 mg to 8 mg of aflibercept for the management of neovascular age-related macular degeneration and diabetic macular edema and transitioning a patient who has good control with aflibercept to a newer therapy.

M-ali-khan
Bali-khan
Snamd
Dme
Aflibercept
Switching-dose

Key Clinical Findings From the PULSAR and PHOTON Trials for High-Dose Aflibercept

M. Ali Khan, MD, FACS, FASRS, reviews the PULSAR and PHOTON clinical trials of high-dose aflibercept for treatment of nAMD and DME.

M-ali-khan
Bali-khan
Snamd
Dme
Aflibercept
Impulsar
Photon
Extended-durability

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.